相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+ Treg cells in pancreatic ductal adenocarcinoma
X. Wang et al.
ONCOGENE (2017)
Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts
Giuseppina Comito et al.
ONCOTARGET (2017)
Discovery of IDO1 Inhibitors: From Bench to Bedside
George C. Prendergast et al.
CANCER RESEARCH (2017)
Immune modulation of CD4+CD25+ regulatory T cells by zoledronic acid
Hsien Liu et al.
BMC IMMUNOLOGY (2016)
Targeting regulatory T cells in tumors
Chang Liu et al.
FEBS JOURNAL (2016)
Zoledronic acid in the management of metastatic bone disease
Thomas Polascik
Therapeutics and Clinical Risk Management (2016)
The differential anti-tumour effects of zoledronic acid in breast cancer - evidence for a role of the activin signaling pathway
Caroline Wilson et al.
BMC CANCER (2015)
PD-1 Upregulated on Regulatory T Cells during Chronic Virus Infection Enhances the Suppression of CD8+ T Cell Immune Response via the Interaction with PD-L1 Expressed on CD8+ T Cells
Hyo Jin Park et al.
JOURNAL OF IMMUNOLOGY (2015)
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
M. Gnant et al.
ANNALS OF ONCOLOGY (2015)
Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma
Iris Chiara Salaroglio et al.
ONCOTARGET (2015)
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
Robert Coleman et al.
LANCET ONCOLOGY (2014)
The anti-tumour effects of zoledronic acid
Jamal Zekri et al.
JOURNAL OF BONE ONCOLOGY (2014)
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
R. Coleman et al.
ANNALS OF ONCOLOGY (2013)
Suppression, subversion and escape: the role of regulatory T cells in cancer progression
K. Oleinika et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid
Toni Ibrahim et al.
CANCER CELL INTERNATIONAL (2012)
Tumor-Derived Chemokine CCL5 Enhances TGF-β-Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells
Li-Yuan Chang et al.
CANCER RESEARCH (2012)
High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote Vγ9Vδ2 T-Cell Chemotaxis and Cytotoxicity In Vivo
Ismahene Benzaid et al.
CANCER RESEARCH (2011)
Early Detection of Tumor Cells by Innate Immune Cells Leads to Treg Recruitment through CCL22 Production by Tumor Cells
Julien Faget et al.
CANCER RESEARCH (2011)
Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross-Talk between Vγ9Vδ2 T Cells, αβ CD8+ T Cells, Regulatory T Cells, and Dendritic Cells
Barbara Castella et al.
JOURNAL OF IMMUNOLOGY (2011)
Bisphosphonates pathway
Li Gong et al.
PHARMACOGENETICS AND GENOMICS (2011)
CCL2 Blockade Augments Cancer Immunotherapy
Zvi G. Fridlender et al.
CANCER RESEARCH (2010)
Cell-Based Immunotherapy With Mesenchymal Stem Cells Cures Bisphosphonate-Related Osteonecrosis of the Jaw-like Disease in Mice
Takashi Kikuiri et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
Marta Coscia et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells
Andrew J. Rech et al.
CANCER VACCINES (2009)
Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer
Anna Maria Fietta et al.
HUMAN IMMUNOLOGY (2009)
Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
Paul Salama et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
NK-Dependent Increases in CCL22 Secretion Selectively Recruits Regulatory T Cells to the Tumor Microenvironment
Adam W. Mailloux et al.
JOURNAL OF IMMUNOLOGY (2009)
Tumor Regulatory T Cells Potently Abrogate Antitumor Immunity
Zuqiang Liu et al.
JOURNAL OF IMMUNOLOGY (2009)
RANK-RANKL Signaling Pathway Is Critically Involved in the Function of CD4+CD25+ Regulatory T Cells in Chronic Colitis
Teruji Totsuka et al.
JOURNAL OF IMMUNOLOGY (2009)
Tumor-derived TGF-beta Mediates Conversion of CD4(+)Foxp3(+) Regulatory T Cells in a Murine Model of Pancreas Cancer
Tricia A. Moo-Young et al.
JOURNAL OF IMMUNOTHERAPY (2009)
CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer
Yoshiki Mizukami et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Blockade of CTLA-4 on CD4+ CD25+ regulatory T cells abrogates their function in vivo
Simon Read et al.
JOURNAL OF IMMUNOLOGY (2006)
FOXP3 controls regulatory T cell function through cooperation with NFAT
Yongqing Wu et al.
CELL (2006)
Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinorna
Udaya K. Liyanage et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Regulatory T cells and innate immune regulation in tumor immunity
Rong-Fu Wang
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2006)
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
J Dannull et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+CD25+ T regulatory cell activities in lung cancer
S Sharma et al.
CANCER RESEARCH (2005)
The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase
CM Robinson et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2005)
分享论文
